Home > Touro College New York > Lander College of Arts and Sciences > The Science Journal of the Lander College of Arts and Sciences > Vol. 7 > No. 2
The Science Journal of the Lander College of Arts and Sciences
Abstract
Photopheresis, also known as Extracorporeal Photopheresis (ECP) is making inroads in treatment of previously untreatable diseases. As the medical world has delved deeper into, Although the mechanisms of photopheresis are largely unknown, increasingly detailed studies have proven its efficacy. The lack of side effects has made photopheresis an ideal option for patients. The treatment is also versatile enough that it can be used as a mono-therapy or as a supplement to other traditional therapies. The use of photopheresis has been proven successful in the treatment of cutaneous T-cell lymphoma (CTCL) and graft-versus-host disease (GvHD), and is currently being administered for immune system disorders, bone marrow, or stem cell implantation, liver, heart, or lung transplants (where there is fear of rejection) and any
Recommended Citation
Lederer, C. (2014). Current Research of Extracorporeal Photopheresis and Future Applications. The Science Journal of the Lander College of Arts and Sciences, 7(2). Retrieved from https://touroscholar.touro.edu/sjlcas/vol7/iss2/11
